Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...

The venture capital landscape in Q1 2025 has reached a fever pitch, with funding soaring to its highest level in nearly three ...

Sapio Sciences has integrated the NVIDIA BioNeMo platform into its lab informatics platform, enhancing AI-driven ...

While I see generative AI emerging as healthcare’s most transformative disruptor, its full potential relies on robust data ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.